Inventor
Scott P. Bruder
Inventor
Owings Mills, MD, US
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61KPreparations for medical, dental or toiletry purposes23%
C12NMicroorganisms or enzymes11%
A61FFilters implantable into blood vessels9%
A61LMethods or apparatus for sterilising materials or objects in general8%
C07KPeptides8%
A61BDiagnosis6%
C12YEnzymes3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
A61JContainers specially adapted for medical or pharmaceutical purposes2%
PatentTitleYear
8,895,540'Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor'20148,877,193'Transdiscal administration of anti-TNFα antibodies and growth differentiation factors'20148,728,523'Transdiscal administration of specific inhibitors of pro-inflammatory cytokines'20148,361,467'Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints'20138,313,742'Cell-containing bone graft material'20128,137,408'Autologous bone graft material'20127,553,827'Transdiscal administration of cycline compounds'20097,429,378'Transdiscal administration of high affinity anti-MMP inhibitors'20087,175,336'Graft delivery system'20077,029,666'Uses for non-autologous mesenchymal stem cells'20066,863,900'Regeneration and augmentation of bone using mesenchymal stem cells'20056,541,024'Regeneration and augmentation of bone using mesenchymal stem cells'20036,482,231'Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative'20026,379,953'Ligands that modulate differentiation of mesenchymal stem cells'20026,355,239'Uses for non-autologous mesenchymal stem cells'20026,022,540'Ligands that modulate differentiation of mesenchymal stem cells'20005,942,225'Lineage-directed induction of human mesenchymal stem cell differentiation'19995,736,396'Lineage-directed induction of human mesenchymal stem cell differentiation'19985,643,736'Monoclonal antibodies for human osteogenic cell surface antigens'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2006Patents assigned to OSIRIS THERAPEUTICS INC (8)· patent assignee history
1997–1998Based in Moreland Hills, OH, US· patent location history
1999–2005Based in Owings Mills, MD, US· patent location history
2002–2006Based in Waltham, MA, US· patent location history
2007–2014Based in Sudbury, MA, US· patent location history
2008–2013Patents assigned to DEPUY SPINE INC (4)· patent assignee history
2009–2014Based in Franklin Lakes, NJ, US· patent location history
2012–2014Patents assigned to BRUDER SCOTT (5)· patent assignee history
2012–2014Patents assigned to KADIYALA SUDHAKAR (5)· patent assignee history
2013–2014Patents assigned to ATTAWIA MOHAMED (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| OSIRIS THERAPEUTICS INC | 8 | 1997–2006 |
| BRUDER SCOTTself | 5 | 2012–2014 |
| KADIYALA SUDHAKAR | 5 | 2012–2014 |
| ATTAWIA MOHAMED | 4 | 2013–2014 |
| DEPUY SPINE INC | 4 | 2008–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Owings Mills, Maryland, US | 6 | 1999–2005 |
| Sudbury, Massachusetts, US | 5 | 2007–2014 |
| Franklin Lakes, New Jersey, US | 4 | 2009–2014 |
| Waltham, Massachusetts, US | 2 | 2002–2006 |
| Moreland Hills, OH, US | 2 | 1997–1998 |